Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration
Dong Liu,Hannah C. Webber,Fuyun Bian,Yangfan Xu,Manjari Prakash,Xue Feng,Ming Yang,Hang Yang,In-Jee You,Liang Li,Liping Liu,Pingting Liu,Haoliang Huang,Chien-Yi Chang,Liang Liu,Sahil H Shah,Anna La Torre,Derek S. Welsbie,Yang Sun,Xin Duan,Jeffrey Louis Goldberg,Marcus Braun,Zdenek Lansky,Yang Hu
DOI: https://doi.org/10.1101/2024.04.02.587832
2024-04-03
Abstract:Optineurin (OPTN) mutations are linked to amyotrophic lateral sclerosis (ALS) and normal tension glaucoma (NTG), but a relevant animal model is lacking, and the molecular mechanisms underlying neurodegeneration are unknown. We found that OPTN C-terminus truncation (OPTNΔC) causes late-onset neurodegeneration of retinal ganglion cells (RGCs), optic nerve (ON), and spinal cord motor neurons, preceded by a striking decrease of axonal mitochondria. Surprisingly, we discover that OPTN directly interacts with both microtubules and the mitochondrial transport complex TRAK1/KIF5B, stabilizing them for proper anterograde axonal mitochondrial transport, in a C- terminus dependent manner. Encouragingly, overexpressing OPTN/TRAK1/KIF5B reverses not only OPTN truncation-induced, but also ocular hypertension-induced neurodegeneration, and promotes striking ON regeneration. Therefore, in addition to generating new animal models for NTG and ALS, our results establish OPTN as a novel facilitator of the microtubule-dependent mitochondrial transport necessary for adequate axonal mitochondria delivery, and its loss as the likely molecular mechanism of neurodegeneration.
Neuroscience